Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer

Biomarkers

Volumn 17, Issue 3, 2012, Pages 216-222

  Kwon, Hyuk Chan ^a   Kim, Sung Hyun ^a   Oh, Sung Yong ^a   Lee, Suee ^a   Lee, Ji Hyun ^a   Choi, Hong Jo ^a   Park, Ki Jae ^a   Roh, Mee Sook ^a   Kim, Seung Geun ^b   Kim, Hyo Jin ^a   Lee, Jong Hoon ^a  

^a Dong A University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Colorectal carcinoma; Neutrophil lymphocyte ratio; Platelet lymphocyte ratio

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; THROMBOCYTE COUNT;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS;

EID: 84860358285     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.656705     Document Type: Article

References (32)

1. Alexandrakis MG, Passam FH, Moschandrea IA, Christophoridou AV, Pappa CA, Coulocheri SA, Kyriakou DS. (2003). Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol 26:135-140. (Pubitemid 36443554)
2. Ali AA, McMillan DC, Matalka II, McNicol AM, McArdle CS. (2004). Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer. Eur J Surg Oncol 30:292-295. (Pubitemid 38425647)
3. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. (2010). Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 200:197-203.
4. Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G, Wu XJ, Lu ZH, Lin JZ, Kong LH, Wan DS, Pan ZZ. (2010). Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25:1427-1433.
5. Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, Vecchiato N, Macrì E, Fornasarig M, Boiocchi M. (1999). High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 154:1805-1813. (Pubitemid 29262862)
6. Dutta S, Crumley AB, Fullarton GM, Horgan PG, McMillan DC. (2011). Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg 35:1861-1866.
7. Eaden JA, Abrams KR, Mayberry JF. (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526-535. (Pubitemid 32234798)
8. Graf W, Bergström R, Påhlman L, Glimelius B. (1994). Appraisal of a model for prediction of prognosis in advanced colorectal cancer. Eur J Cancer 30A:453-457. (Pubitemid 24171949)
9. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP. (2008). Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 34:55-60. (Pubitemid 350296756)
10. Hauser CA, Stockler MR, Tattersall MH. (2006). Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Support Care Cancer 14:999-1011. (Pubitemid 44451305)
11. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, Tatsuta M, Satomi T. (2002). Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9:287-291. (Pubitemid 34298634)
12. Ishizuka M, Nagata H, Takagi K, Kubota K. (2009). Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg 250:268-272.
13. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, Lee JS. (2011). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 43:1-11.
14. Klinger MH, Jelkmann W. (2002). Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22:913-922. (Pubitemid 35155690)
15. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. (2003). Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6:283-287. (Pubitemid 38987537)
16. Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS, Kim HJ, Kwon HC, Lee JH. (2010). Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 10:203.
17. Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, Kim C. (2007). Prognostic significance of metastatic lymph node ratio in nodepositive colon carcinoma. Ann Surg Oncol 14:1712-1717. (Pubitemid 46791006)
18. Lord BI, Bronchud MH, Owens S, Chang J, Howell A, Souza L, Dexter TM. (1989). The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 86:9499-9503. (Pubitemid 20010454)
19. MacDonald N. (2007). Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/ supportive care. J Support Oncol 5:157-62; discussion 164. (Pubitemid 46929225)
20. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Viganò A, Larkin P, De Conno F, Hanks G, Kaasa S; Steering Committee of the European Association for Palliative Care. (2005). Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240-6248.
21. McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, McArdle CS. (1995). A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170:319-322.
22. Menges T, Engel J, Welters I, Wagner RM, Little S, Ruwoldt R, Wollbrueck M, Hempelmann G. (1999). Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med 27:733-740. (Pubitemid 29218205)
23. Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, van Krieken JH. (2001). Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect-a histopathological and immunohistochemical study. BMC Cancer 1:7.
24. Pritchard CC, Grady WM. (2011). Colorectal cancer molecular biology moves into clinical practice. Gut 60:116-129.
25. Roxburgh CS, McMillan DC. (2010). Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:149-163.
26. Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC. (2009). Comparison of the prognostic value of inflammationbased pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249:788-793.
27. Salazar-Onfray F, López MN, Mendoza-Naranjo A. (2007). Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev 18:171-182. (Pubitemid 46401435)
28. Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, Milroy R. (2002). The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable nonsmall cell lung cancer. Br J Cancer 87:264-267.
29. Sierko E, Wojtukiewicz MZ. (2004). Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30:95-108. (Pubitemid 38457304)
30. Ulich TR, del Castillo J, Keys M, Granger GA, Ni RX. (1987). Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-α-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol 139:3406-3415. (Pubitemid 18021995)
31. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. (2005). Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181-184. (Pubitemid 41254421)
32. World Health Organization Global burden of disease 2004. http://www.who.int/healthinfo/global-burden-disease/2004-report- update/en/.